Tudor Investment Corp’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-14,397
| Closed | -$625K | – | 1902 |
|
|
2021
Q2 | $625K | Buy |
+14,397
| New | +$625K | 0.01% | 1024 |
|
|
2020
Q1 | – | Sell |
-13,901
| Closed | -$297K | – | 1278 |
|
|
2019
Q4 | $297K | Sell |
13,901
-10,508
| -43% | -$225K | 0.01% | 866 |
|
|
2019
Q3 | $456K | Buy |
24,409
+6,793
| +39% | +$127K | 0.02% | 729 |
|
|
2019
Q2 | $460K | Buy |
17,616
+9,078
| +106% | +$237K | 0.01% | 733 |
|
|
2019
Q1 | $219K | Buy |
+8,538
| New | +$219K | 0.01% | 960 |
|
|
2018
Q1 | – | Sell |
-5,581
| Closed | -$217K | – | 1184 |
|
|
2017
Q4 | $217K | Buy |
+5,581
| New | +$217K | 0.01% | 934 |
|
|
2016
Q4 | – | Sell |
-4,224
| Closed | -$155K | – | 1551 |
|
|
2016
Q3 | $155K | Buy |
4,224
+1,299
| +44% | +$47.7K | ﹤0.01% | 1278 |
|
|
2016
Q2 | $65K | Hold |
2,925
| – | – | ﹤0.01% | 1370 |
|
|
2016
Q1 | $61K | Buy |
2,925
+814
| +39% | +$17K | ﹤0.01% | 1405 |
|
|
2015
Q4 | $64K | Buy |
2,111
+220
| +12% | +$6.67K | ﹤0.01% | 1413 |
|
|
2015
Q3 | $47K | Buy |
1,891
+20
| +1% | +$497 | ﹤0.01% | 1412 |
|
|
2015
Q2 | $60K | Buy |
1,871
+490
| +35% | +$15.7K | ﹤0.01% | 1397 |
|
|
2015
Q1 | $49K | Buy |
+1,381
| New | +$49K | ﹤0.01% | 1392 |
|
|
2014
Q3 | – | Sell |
-1,195
| Closed | -$43K | – | 1459 |
|
|
2014
Q2 | $43K | Buy |
1,195
+26
| +2% | +$936 | ﹤0.01% | 1116 |
|
|
2014
Q1 | $45K | Buy |
+1,169
| New | +$45K | ﹤0.01% | 1135 |
|